SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,000 | -87.1% | 1,527 | -78.4% | 0.00% | – |
| Q4 2020 | $85,000 | +400.0% | 7,082 | +267.7% | 0.00% | – |
| Q3 2020 | $17,000 | -57.5% | 1,926 | -42.1% | 0.00% | – |
| Q2 2020 | $40,000 | +33.3% | 3,325 | -24.4% | 0.00% | – |
| Q4 2019 | $30,000 | -6.2% | 4,400 | +44.6% | 0.00% | – |
| Q3 2019 | $32,000 | +18.5% | 3,043 | +2.5% | 0.00% | – |
| Q2 2019 | $27,000 | – | 2,969 | +11319.2% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 26 | -92.9% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 366 | +109.1% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 175 | +0.6% | 0.00% | – |
| Q2 2018 | $2,000 | – | 174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |